DOMS Industries Subsidiary Receives GST Order
DOMS Industries Limited announced on March 21, 2026, that its subsidiary, Uniclan Healthcare Private Limited, has received an order from the Office of Superintendent of Central Taxes (GST), Thane. The order pertains to the financial year 2021-22 and was received on March 20, 2026.The order relates to the alleged wrongful availment and utilization of Input Tax Credit (ITC) without the actual receipt of underlying goods or services. The total amount for recovery of alleged inadmissible ITC, along with penalty and interest, is ₹ 5,22,692 and ₹ 10,45,384 respectively.
According to DOMS Industries, Uniclan Healthcare is assessing legal remedies and plans to submit a response within the prescribed timeframe. The company stated that the order is not expected to have a material impact on the financial, operational, or other activities of DOMS Industries Limited.
Below is a summary of the order details:
| Sr. No. | Particulars | Disclosure |
|---|---|---|
| 1 | Name of the Authority | Office of Superintendent of Central Taxes (CGST), Thane |
| 2 | Nature and details of the action(s) taken or order(s) passed. | The Office of Superintendent of Central Taxes (CGST), Thane, has issued the said Order under Section 74 and 122 of the CGST Act and relevant sections of MGST Act, 2017 for wrongful availment of Input Tax Credit (' ITC ') and utilisation of such ITC without actual receipt of the underlying goods/ services. |
| 3 | Date of receipt of direction or order, including any ad-interim or interim orders, or any other communication from the authority. | March 20, 2026 |
| 4 | Details of the violation(s)/ contravention(s) committed or alleged to be committed. | The said Order is issued for recovery of alleged inadmissible ITC amounting to ₹ 5,22,692 along with penalty of ₹ 10,45,384 and interest as calculated under Section 50 of CGST Act, 2017. |
| 5 | Impact on financial, operation or other activities of the listed entity, quantifiable in monetary terms to the extent possible. | The Company's subsidiary is evaluating appropriate legal remedy against the said Order and is proposing to file a response to the same within the prescribed time limit. Further, there is no material impact on the financial, operations and/ or other activities of the Company due to the Order. |
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Last edited by a moderator: